These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1156 related articles for article (PubMed ID: 17529859)
1. Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005. Messina AF; Katz-Gaynor K; Barton T; Ahmad N; Ghaffar F; Rasko D; McCracken GH Pediatr Infect Dis J; 2007 Jun; 26(6):461-7. PubMed ID: 17529859 [TBL] [Abstract][Full Text] [Related]
2. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas. Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357 [TBL] [Abstract][Full Text] [Related]
3. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. Pai R; Moore MR; Pilishvili T; Gertz RE; Whitney CG; Beall B; J Infect Dis; 2005 Dec; 192(11):1988-95. PubMed ID: 16267772 [TBL] [Abstract][Full Text] [Related]
4. Serotype 19A is the most common Streptococcus pneumoniae isolate in children with chronic sinusitis. McNeil JC; Hulten KG; Mason EO; Kaplan SL Pediatr Infect Dis J; 2009 Sep; 28(9):766-8. PubMed ID: 19636285 [TBL] [Abstract][Full Text] [Related]
5. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Farrell DJ; Klugman KP; Pichichero M Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873 [TBL] [Abstract][Full Text] [Related]
6. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971 [TBL] [Abstract][Full Text] [Related]
7. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. Moore MR; Gertz RE; Woodbury RL; Barkocy-Gallagher GA; Schaffner W; Lexau C; Gershman K; Reingold A; Farley M; Harrison LH; Hadler JL; Bennett NM; Thomas AR; McGee L; Pilishvili T; Brueggemann AB; Whitney CG; Jorgensen JH; Beall B J Infect Dis; 2008 Apr; 197(7):1016-27. PubMed ID: 18419539 [TBL] [Abstract][Full Text] [Related]
9. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Jacobs MR; Good CE; Bajaksouzian S; Windau AR Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493 [TBL] [Abstract][Full Text] [Related]
10. Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine. Dias R; Caniça M FEMS Immunol Med Microbiol; 2007 Oct; 51(1):35-42. PubMed ID: 17854472 [TBL] [Abstract][Full Text] [Related]
11. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Byington CL; Samore MH; Stoddard GJ; Barlow S; Daly J; Korgenski K; Firth S; Glover D; Jensen J; Mason EO; Shutt CK; Pavia AT Clin Infect Dis; 2005 Jul; 41(1):21-9. PubMed ID: 15937758 [TBL] [Abstract][Full Text] [Related]
12. Emergence of invasive pneumococcal disease caused by multidrug-resistant serotype 19A among children in Barcelona. Muñoz-Almagro C; Esteva C; de Sevilla MF; Selva L; Gene A; Pallares R J Infect; 2009 Aug; 59(2):75-82. PubMed ID: 19576637 [TBL] [Abstract][Full Text] [Related]
13. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)]. Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998 [TBL] [Abstract][Full Text] [Related]
14. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Dagan R Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365 [TBL] [Abstract][Full Text] [Related]
15. Emergence of antimicrobial-resistant serotype 19A Streptococcus pneumoniae--Massachusetts, 2001-2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Oct; 56(41):1077-80. PubMed ID: 17947966 [TBL] [Abstract][Full Text] [Related]
16. Evolving picture of invasive pneumococcal disease in massachusetts children: a comparison of disease in 2007-2009 with earlier periods. Yildirim I; Stevenson A; Hsu KK; Pelton SI Pediatr Infect Dis J; 2012 Oct; 31(10):1016-21. PubMed ID: 22673142 [TBL] [Abstract][Full Text] [Related]
17. Distribution of serotypes and antibiotic resistance of invasive pneumococcal disease isolates among children aged 5 years and under in Saudi Arabia (2000-2004). Shibl AM Clin Microbiol Infect; 2008 Sep; 14(9):876-9. PubMed ID: 18844690 [TBL] [Abstract][Full Text] [Related]
18. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165 [TBL] [Abstract][Full Text] [Related]
19. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605 [TBL] [Abstract][Full Text] [Related]
20. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Isaacman DJ; McIntosh ED; Reinert RR Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]